Wei Jiang
Wei Jiang's purchase track record
Wei Jiang has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/16/2026 | WAT | $145K | +23.4% | +41.4% | +13.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
STAAR Surgical Names New VP, Faces High Valuation Questions. STAAR Surgical appointed Andrew Pilon as Vice President of Business Development. Recent articles discuss whether the stock is undervalued or risky, noting its high trailing P/E of 283.5. The stock is currently trading near a key support level, with analyst targets ranging from $19.00 to $37.00.
Transaction History
| WAT | ▲ Buy | Grant | 57 | $0 | 9/30/2026 | View on chart |
| WAT | ▲ Buy | Grant | 67 | $0 | 6/30/2026 | View on chart |
| STAA | ▲ Buy | Option Exercise | 10,683 | $0 | 6/18/2026 | View on chart |
| WAT | ▲ Buy | Grant | 64 | $0 | 3/31/2026 | View on chart |
| WAT | ▲ Buy | Open Market | 500 | $145K | 3/16/2026 | View on chart |
| WAT | ▲ Buy | Grant | 23 | $0 | 2/25/2026 | View on chart |
| STAA | ▲ Buy | Option Exercise | 20,967 | $0 | 1/12/2026 | View on chart |
| WAT | ▲ Buy | Grant | 307 | $0 | 1/2/2026 | View on chart |
| WAT | ▲ Buy | Grant | 60 | $0 | 12/31/2025 | View on chart |
| STAA | ▲ Buy | Option Exercise | 20,967 | $0 | 11/12/2025 | View on chart |
| WAT | ▲ Buy | Grant | 73 | $0 | 9/30/2025 | View on chart |
| STAA | ▲ Buy | Option Exercise | 20,967 | $0 | 8/12/2025 | View on chart |
| WAT | ▲ Buy | Grant | 68 | $0 | 6/30/2025 | View on chart |
| WAT | ▲ Buy | Grant | 53 | $0 | 3/31/2025 | View on chart |
| WAT | ▲ Buy | Grant | 319 | $0 | 1/2/2025 | View on chart |
| WAT | ▲ Buy | Grant | 81 | $0 | 12/31/2024 | View on chart |
| WAT | ▲ Buy | Grant | 63 | $0 | 9/30/2024 | View on chart |
| WAT | ▲ Buy | Grant | 64 | $0 | 6/28/2024 | View on chart |
| STAA | ▲ Buy | Grant | 2,244 | $0 | 6/20/2024 | View on chart |
| STAA | ▲ Buy | Grant | 1,299 | $0 | 3/12/2024 | View on chart |
| WAT | ▲ Buy | Grant | 334 | $0 | 1/2/2024 | View on chart |
| WAT | ▲ Buy | Grant | 318 | $0 | 1/3/2023 | View on chart |
| WAT | ▲ Buy | Grant | 301 | $0 | 1/3/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Waters Launches AI Link for LC-MS Workflows
Waters Corporation introduced AI Link, a tool designed to advance AI-enabled LC-MS workflows from research to release. This product launch highlights the company's focus on integrating artificial intelligence into its laboratory solutions. Additionally, TD Cowen raised its price target to $515, reflecting continued analyst interest in the stock's potential.
Waters Launches AI Link for LC-MS Workflows. Waters Corporation introduced AI Link, a tool designed to advance AI-enabled LC-MS workflows from research to release. This product launch highlights the company's focus on integrating artificial intelligence into its laboratory solutions. Additionally, TD Cowen raised its price target to $515, reflecting continued analyst interest in the stock's potential.